Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.

Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group. J Clin Oncol. 1996 Aug; 14(8):2242-9.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antiemetics
Cisplatin
Double-Blind Method
Female
Humans
Indoles
Infusions, Intravenous
Male
Middle Aged
Nausea
Neoplasms
Ondansetron
Quinolizines
Remission Induction
Serotonin Antagonists
United States
Vomiting

authors with profiles

Rudolph Navari